Biography of Jean-Paul Kress
Last update: February 18, 2024Career
Jean-Paul was President and Chief Executive Officer at Syntimmune, and Executive Vice President, President International and Head of Global Therapeutic Operations at Biogen.
Jean-Paul Kress is currently- Chief Executive Officer at MorphoSys US - View - MorphoSys US org chart
- Chief Executive Officer at Morphosys - View - Morphosys org chart
Create your alert
to follow the career of Jean-Paul Kress.
Education
Jean-Paul Kress has a Medical Doctorate from Université René Descartes (Paris V) and a MSc Molecular and Cellular Pharmacology from Ecole Normale Supérieure.
They have also studied at Université René Descartes (Paris V) :
Find more alumni from Université René Descartes (Paris V)
They have also studied at Ecole Normale Supérieure :
Find more alumni from Ecole Normale Supérieure
More about Jean-Paul Kress
Selected links
Do you need to know more about Jean-Paul Kress? More results.
Participate
Social media
- Jean-Paul Kress on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Jean-Paul Kress
The colleagues of Jean-Paul Kress
Company Colleagues
- At MorphoSys US, Jean-Paul Kress has 2 colleagues including Tony Gulczynski (Trade & Distribution), Jill Robinson (Public Policy & Advocacy)…
- At Morphosys, Jean-Paul Kress has 24 colleagues including George Golumbeski (Vice Chairman of the Board), Krisja Vermeylen (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Jean-Paul Kress has 19,369 colleagues in 1,861 companies located in 69 countries. 8,437 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Jean-Paul Kress.
Get in Touch
and ask for Jean-Paul Kress.
